mRNA Therapeutics: To The Liver, And Beyond!
Source: Cytiva
In addition to an introduction to our guests, Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D., this segment from the Bioprocess Online Live event, mRNA Update: Beyond Prophylactic Vaccines, features Dr. VanCott addressing progress on targets beyond the liver.
        access the Video!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
            
        
        
            Case Studies & White Papers
            
        
        
            Extensive Product Database
            
        
        
            Members-Only Premium Content
            
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
        Subscribe to Bioprocess Online
        X
    
    
        Subscribe to Bioprocess Online